Table 4.
Association between diagnosis, hospitalization, and highly probable COVID-19 based on signs and symptoms, over the previous 6 weeks in 941 IBD patients and 869 corresponding controls.
| COVID-19 | IBD patients (%) | Controls (%) | Odds ratio, 95% confidence intervala | p-value | Odds ratio, 95% confidence intervalb | p-value |
|---|---|---|---|---|---|---|
| Diagnosis of COVID-19 No Yes Not investigated Missing Hospitalization for COVID-19 No Yes Missing Likely COVID-19 based on fever, ageusia/anosmia, and cough/myalgia No Yes |
393 (41.8) 2 (0.2) 545 (57.9) 1 (0.1) 938 (99.7) 1 (0.1) 2 (0.2) 905 (96.2) 36 (3.8) |
366 (42.1) 10 (1.2) 489 (56.3) 4 (0.5) 859 (98.9) 6 (0.7) 4 (0.5) 815 (93.8) 54 (6.3) |
1c 0.19 (0.02–0.88) 1c 0.15 (0.00–1.26) 1c 0.53 (0.33–0.84) |
0.030 0.099 0.006 |
1c 0.14 (0.03–0.67) 1c 0.14 (0.02–1.17) 1c 0.54 (0.34–0.86) |
0.024 0.07 0.0018 |
a
Estimated from a logistic regression model adjusted for age, sex, area of residence, and education.
b
Estimated from a logistic regression model further adjusted for BMI, smoking, oncologic diseases, rheumatologic diseases, use of acetaminophen, aspirin and Nonsteroidal anti-inflammatory drugs, vitamin D intake and vaccination for seasonal flu.
c
Reference category.